Pharma Base SA
29.0 FTEThe score of Pharma Base shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2024
Change 2021 → 2024: Revenue +34 % Equity -39 % Total assets +20 % Headcount (avg FTE) +68 %
Accounts of the company itself (not consolidated). Consolidated group accounts are also filed: they are in the full file.
The full file covers 9 financial years; a free account shows 2. →Pharma Base's annual accounts
| 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|
| Revenue | €75.2m | ||||
| Net result | 178,876 € | ||||
| Equity | €2.53m | ||||
| Cash | 645,070 € | ||||
| EBITDA | 480,102 € | ||||
| Total assets | €21.1m |
Filed annual accounts
- Year ended 31 Dec 2024filed on 23 Jun 2025
- Year ended 31 Dec 2023filed on 31 Jul 2024
- Year ended 31 Dec 2022filed on 11 Jul 2023
- Year ended 31 Dec 2021filed on 22 Jun 2022
- Year ended 31 Dec 2020filed on 24 Jun 2021
Pharma Base's financial analysis
- Solvency12.0%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharma Base
Pharma Base's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0441.943.282
- VAT number
- BE0441943282
- Peppol
- Registered · 0208:0441943282 · as of 27 Oct 2026
- Legal form
- SA
- Incorporated
- 10 Oct 1990
- Registered office
- 3600 Genk
- Size
- Small · 29.0 FTE
- Latest accounts
- 2024 · filed on 23 Jun 2025
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Pharma Base (SA) has been based in Genk since 1990, active in: wholesale of pharmaceutical and medical goods. For 2024, it reports revenue of €75.2m, a net profit of 178,876 € and equity of €2.53m. With 29.0 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 12.0%, below the median of its sector (46.0%).
Companies similar to Pharma Base
Companies in the same business, of comparable size and area, outside its group.
- BePharBel Manufacturing Manufacture of basic pharmaceutical products Courcelles · balance sheet €27.4m
- Euro - Medic Wholesale of pharmaceutical and medical goods Deinze · balance sheet €14.1m
- Exphar Wholesale of pharmaceutical and medical goods Nivelles · balance sheet €14.1m
- Thea Pharma Wholesale of pharmaceutical and medical goods Ghent · balance sheet €16.7m
- Organon Belgium Wholesale of pharmaceutical and medical goods Brussels · balance sheet €25.2m
- Melisana Wholesale of pharmaceutical and medical goods Evere · balance sheet €15.4m
- P&G Health Belgium Wholesale of pharmaceutical and medical goods Grimbergen · balance sheet €20.8m
- Aurobindo Wholesale of pharmaceutical and medical goods Jette · balance sheet €22.0m
Frequently asked questions about Pharma Base
What is the revenue of Pharma Base?
According to the 2024 annual accounts filed with the NBB, the revenue of Pharma Base amounts to 75,243,950 €.
What is the VAT number of Pharma Base?
In Belgium, the VAT number is the company number prefixed with BE: BE0441943282 for Pharma Base, if the company is VAT-registered. Its company number (CBE) is 0441.943.282.
Where is the registered office of Pharma Base?
According to the CBE register, the registered office of Pharma Base is in 3600 Genk.
What is the equity of Pharma Base?
At the close of the 2024 financial year, the equity of Pharma Base amounts to 2,527,055 €, a solvency of 12.0% of total assets.
How many people work at Pharma Base?
29.0 full-time equivalents on average according to the 2024 social balance sheet.
Who manages Pharma Base?
The register lists 2 active mandates at Pharma Base. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharma Base
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →